Literature DB >> 19919932

Synthesis, anticancer and cytostatic activity of some 6H-indolo[2,3-b]quinoxalines.

Subhas S Karki1, Rahul Hazare, Sujeet Kumar, Vivek S Bhadauria, Jan Balzarini, Erik De Clercq.   

Abstract

Various 6-aralkyl-9-substituted-6H-indolo[2,3-b]quinoxalines were synthesized by reaction of 1,5-disubstituted 2,3-dioxo-2,3-dihydroindole and orthophenylene diamine. Appreciable anticancer activity of compounds 5b, 5d, 5g and 5l at various cell lines among 59 human tumor cell panels was observed. All the synthesized compounds were evaluated for cytostatic activity against human Molt 4/C8 and CEM T-lymphocytes as well as for murine L1210 leukemia cells. Compound 5h exhibited an I C50 of 23 micromol L(-1) against Molt 4/C8 and 38 micromol L(-1) against CEM compared to melphalan 3.2 micromol L(-1) and 2.5 micromol L(-1), respectively. The IC(50) for compound 7i against L1210 was 7.2 micromol L(-1) compared to melphalan 2.1 micromol L(-1).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919932     DOI: 10.2478/v10007-009-0040-9

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  2 in total

1.  Unusual Friedlander reactions: a route to novel quinoxaline-based heterocycles.

Authors:  Tharallah A Shoker; Khaled I Ghattass; James C Fettinger; Mark J Kurth; Makhluf J Haddadin
Journal:  Org Lett       Date:  2012-07-11       Impact factor: 6.005

2.  Novel Isoquinolinamine and Isoindoloquinazolinone Compounds Exhibit Antiproliferative Activity in Acute Lymphoblastic Leukemia Cells.

Authors:  Catrin Roolf; Jan-Niklas Saleweski; Arno Stein; Anna Richter; Claudia Maletzki; Anett Sekora; Hugo Murua Escobar; Xiao-Feng Wu; Matthias Beller; Christian Junghanss
Journal:  Biomol Ther (Seoul)       Date:  2019-04-02       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.